ArticleJHEP reports : innovation in hepatology2026
Identifying sorafenib benefit among patients with hepatocellular carcinoma: A transcriptomic and genomic approach.
Sun Young Yim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it